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As clinical pathway adoption continues worldwide, it is necessary to establish adherence measurement
methods in order to understand the difﬁculties and results of implementation. Adherence measurement
literature mostly provides binary measurements of adherence to guidelines regarding individual medical
activities over patient groups. The resulting measurements are of limited value in view of the pathways
actually followed by individual patients. We develop and test dynamic programming formulations for
adherence measurement in clinical pathways – based on partially ordered data in medical records and
pathway deﬁnitions. With these newmethods at hand, we analyze clinical pathway adherence at the Car-
diovascular Center of Maastricht University Medical Center.
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As health care costs are growing from 10 towards 20 percent of
GDP in most developed countries [1,2], the need for cost reduction
and efﬁciency improvement is strongly felt. At the same time, sci-
ence and technology progress and obedient patients change into
demanding customers, increasing the pressure to deliver high
quality, customized service. Hence, many health care organizations
seek operational innovations that combine high quality with low
cost as they have been successfully introduced in other industries.
Ford’s successful introduction of standardization in the automotive
industry brought higher quality and lower cost already in the early
20th century. Since then, many companies and industries have fol-
lowed, and the operations management discipline has adopted and
further developed Ford’s seminal ideas. The concepts of Total Qual-
ity Management and 6r are among the most widely adopted suc-
cessors in the global manufacturing industry. Service industry
however has proven to be more unruly. Whereas successful imple-
mentation of standardization techniques have taken place in vari-
ous service industries, ranging from fast food restaurants to health
care, other service processes have been concluded to be inappro-
priate for standardization. By nature, and because of the high de-
gree of customization, service operations often appear to
combine badly with standardization. This holds especially for
health care processes whose professionals have cynically referred
to standardization as ‘cookbook medicine’ [3].
Canadian Shouldice Hospital adopted a standardized approach
for abdominal wall hernia surgery as early as 1945, and has provenll rights reserved.
de Klundert).to deliver low cost services with faster recovery and fewer compli-
cations than comparable organizations that use traditional meth-
ods [4]. Shouldice however does not accept every patient but
aims to accept just those for which their processes are designed
and optimized. This cookbook approach of Shouldice (referred to
as the McDonald’s approach by Dr. Earl Shouldice, founder of
Shouldice Hospital [5]), is not considered to be appropriate for all
cure processes, and as will be described shortly, mixed results
are being reported in literature.
Scientiﬁc literature usually refers to standardized, typically evi-
dence based, health care processes, whether for diagnosis or for
treatment, by the term clinical pathways. A common deﬁnition of
clinical pathways is: ‘management plans that display goals for pa-
tients and provide the corresponding ideal sequence and timing of
staff actions to achieve those goals with optimal efﬁciency’ [6]. We
refer to [7] for a survey that revealed as much as 84 deﬁnitions for
clinical pathways in the years 2000–2003. Clinical pathways are also
akin to clinical guidelines, which can be deﬁned as ‘‘systematically
developed statements to assist practitioner decisions about appro-
priate health care for speciﬁc clinical circumstances” [8,9], and for
which a wide variety of deﬁnitions appears in scientiﬁc literature
as well. Clinical guidelines can be quite detailed, as is further dis-
cussed below, but in principal form generally applicable, evidence
based statements. By their operational nature, clinical pathways
provide detailed operational procedures within a speciﬁc organiza-
tion, and are therefore less general than clinical guidelines. Below
we discuss the modeling of clinical pathways as appropriate for
our research purposes in more detail, and address related literature
on the modeling of clinical pathways and guidelines.
Although some clinical pathway introductions have brought
considerable improvements [10–12], literature paints a mixed
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regarding the adherence to the clinical pathways [10,11,14].
Hence, decision making on implementing or rejecting clinical path-
ways should not be taken lightly. Moreover, not withstanding the
fact that deviations from the cookbook pathways might address
the needs of an individual patient better, deviation from evi-
dence-based pathways might just as well reduce quality of care.
Scientiﬁc literature on clinical pathways however, hardly ad-
dresses in depth analysis of pathway adherence after implementa-
tion, or its improvement. We present a model to measure clinical
pathway adherence, which is able to cope with variations in path-
ways and deviations from pathways. Further, we apply it to real life
data from the years 2001–2005 at the Maastricht University Med-
ical Centre (MUMC).
The aim of this paper is not to determine whether or when
adherence to the pathways is justiﬁed, nor to explore the medical
consequences. The promise of clinical pathways is to increase the
quality of health care while lowering costs, as society requests.
Thus, it is worth to implement best practices, yet still to deviate
if justiﬁed for medical reasons. Consequently, the concept of devi-
ation must be meaningfully deﬁned, and deviations must be sys-
tematically measured and reported. The methodology developed
in this paper therefore provides a systematic approach to deﬁne
and measure deviations, building on arguments of medical experts.
In doing so, it contributes to the understanding of the pros and
cons of clinical pathways, and subsequently to advancing health
care quality and efﬁciency.
2. Literature
Different authors have coined different deﬁnitions for the re-
lated concepts of clinical pathways, critical pathways, and critical
paths. Originally [6], clinical pathways have been typically devel-
oped for high volume, low cost treatment processes. Nevertheless,
many applications [15–17] fall in the domain of diagnosis pro-
cesses, such as diagnosis of myocardial infarction, stroke and deep
venerous thrombosis, domains that are closely related to the case
study under consideration in subsequent sections. Various authors
[15,16] stress the importance and difﬁculty of collecting and pro-
cessing variance data, as understanding and managing variance is
necessary to realize the promise of clinical pathways. Delaney et
al. [17] for instance report better results when restricting the path-
way implementation to patients younger than 70 and surgeons
who are experienced with the system.
Evidence [10–12] conﬁrms that clinical pathways enable to im-
prove quality and efﬁciency simultaneously, or to improve one
without adversely affecting the other. Marrie et al. [12] conclude
from a study on a critical pathway for community-acquired pneu-
monia that efﬁciency has increased without affecting the well-
being of patients adversely. Likewise, Macario et al. [10] report a
decrease in average hospital costs for knee replacement surgery
from $21,709 to $17,618. On the quality side, Panella et al. [11] re-
port various implementations and that heart failure in-patient
mortality rates reduced from 17 percent to below 5 percent in of
these implementations. However, several studies deliver negative
results and report implementation problems because of resistance
to cooperate. Literature surveys have lead to the conclusion that
‘the results of the reported studies should be interpreted with cau-
tion’ [13] and that results of implementing clinical pathways are
heterogeneous in various respects, varying from mortality to
length of stay, and ‘ﬁnd no evidence that care pathways provide
signiﬁcant additional beneﬁt over standard medical care in terms
of major clinical outcomes’ [18].
Despite the mixed ﬁndings in scientiﬁc literature, a recent sur-
vey [19] by the European Pathway Association reveals that experi-
enced professionals rank improvement of quality of care andefﬁciency of care among the most important features of clinical
pathways. Moreover, they report that in many participating
countries the percentage of patients that receive pathway-based
treatment is expected to rise from 15 percent or less to between
40 and 80 percent within the next ﬁve years. Improvement of evi-
dence-based care serves as another important objective in the
survey results, and deﬁning and measuring indicators for
evidence-based medicine is one of the main international trends
[16,19]. Stressing the correlation with quality of care, Caminiti
et al. [4] explicitly address adherence to evidence based clinical
pathways, and report results on a wide scale study. Their results
reveal improvements in adherence (e.g. on cerebral ischemic
stroke), but at the same time demonstrate that even after a thor-
ough implementation approach, the adherence appears to leave
much room for improvement (e.g. for cesarean sections). They con-
clude that the ability and willingness to change plays an important
role in the adherence to clinical pathways.
Lack of adherence, which generates unnecessary health care
expenses of 100 billion dollars in the US [20] has received consid-
erable attention in the literature both from a viewpoint of therapy
adherence by patients and from the perspective of guideline adher-
ence by medical professionals. Different modules to measure
adherence have been reported, some of which take a binary ap-
proach with respect to the adherence to certain pathways, proto-
cols, treatments, or other medical activity. Milchak et al. [21]
thoroughly research treatment adherence per patient as measured
by an algorithm that calculates a numerical adherence score by
weighing a set of binary scores on 22 different criteria. For various
reasons [22–24], the data required to measure whether the actual
cure or care treatment is according to the prescribed guidelines
(pathways or other) is often incomplete or incorrect. Sometimes
information is collected using self-assessment by patients or med-
ical professionals, sometimes from handwritten medical records,
and/or from a set of partially integrated IT systems. The low quality
of the data makes adherence measurement difﬁcult, yet several
practical studies reveal that adherence can indeed be quite poor.
The many successfully completed IT implementations have not
yet reduced the need for adequate information technology to sup-
port quality assessment and improvement in health care [25].
Gardetto et al. [26] and Rood et al. [27] proposed software sys-
tems to assist medical professionals in delivering care according to
the prescribed pathway as deﬁned by a ﬂow chart, and report
improvements in adherence as well as in medical outcomes. In
addition, software systems that send reminder messages to medi-
cal professionals when treatment is required according to evi-
dence-based pathways have been developed and studied with
respect to reminder adherence [28]. A formal language (QUIL) to
deﬁne pathways and adherence, taking complicating issues such
as temporal parameters, acceptable alternative and patient-speci-
ﬁcity into account is proposed by Advani et al. [29]. QUIL does
not allow modeling the (partial) orders in pathway structures
and patient record structures that we encountered in our research
project, and which we believe are of importance to pathway adher-
ence measurement.
The literature on modeling clinical guidelines, by contrast, pro-
vides descriptions of elaborate formal modeling languages and
software systems such as ASBRU, EON, GLIF, PROforma [30–32].
These modeling languages support a variety of 43 ﬂow structures
[30], of which only the relatively small sets of basic control-ﬂows
and advanced branching and synchronization patterns is relevant
in our research. As such, our work can be viewed to address adher-
ence measurement for a simple workﬂow process deﬁnition
language.
In view of the impact adherence might have on the cost and
quality of care, we provide models and algorithms that extend
the simple workﬂow process deﬁnition language with adherence
Echo (Spec)
Consult 
Cons Spec. Nurse
ECG
Lab tests
Echo
CT Scan
Exerc Test 
LF: Antrup.
Consult 
≥ 5.5 cm 
TAAA
Exercise 
Echo:HCU 
Fig. 2. Pathway for aneurysm diagnosis.
J. van de Klundert et al. / Journal of Biomedical Informatics 43 (2010) 861–872 863measurement functionality. These models and algorithms enable
to measure pathway adherence accurately, taking into account ex-
pert opinions on deviations, and relying on a formal pathway
deﬁnition. The deﬁnition supports multidisciplinary process orien-
tation (see e.g. Figs. 1 and 2) and includes precedence relations,
partial orders, parallelism, exclusive alternatives, and nested path-
ways. Exclusive alternatives model the situation where a choice of
appropriate exclusive alternatives exists for a certain medical
action. In such a case, adherence to the pathway means that one
of the alternatives must be selected. The proposed adherence mea-
surement model is more general than models that simply give bin-
ary penalties per violation. Instead, it allows valuing omissions,
substitutes, or additional activities on a continuous scale. In com-
bination with the allowable process ﬂow structures, the thus
deﬁned adherence measurement problem is highly non-trivial.
We propose polynomial algorithms for pathway adherence mea-
surement that rely on techniques from combinatorial optimization.
Remarkably, our dynamic programming approach is akin to se-
quence alignment algorithms developed in molecular biology in
the context of genetic pathways [33]. Since the practical problem
at hand relaxes order preservation constraints within the se-
quences, we embed in the dynamic programming recursion a max-
imum weight matching algorithm [34].
3. Methods: pathway modeling
We now formalize the concept of pathways and pathway adher-
ence as appropriate with current practice in MUMC. The care a pa-
tient receives is deﬁned as a set of activities of various types,
ranging from interventions, to lab tests, to communication.
Although we will not explicitly model it, patient need not be pres-
ent for each of the activities (consider e.g. lab tests). As MUMC
database records on provided care activities specify the date, but
not the starting and ending times of the activities, we adopt the
convention [6,35] that pathways contain consecutive sets of activ-
ities (a set per date). The order in which activities must be per-
formed is not always explicitly speciﬁed.
Deﬁnition 1. An activity is an atomic unit of care delivered to the
patient, as meaningful to execute or record the care.
A set of activities must oftentimes be executed in a prescribed
order. A simple two activity example is a path in which an echo
(activity x) must be taken before its outcomes can be discussed
with the patient in a consult (activity y). As customary, we denote
such precedence relationships by x  y and say x precedes y, or y
succeeds x. Before further developing the precedence relationships,
we ﬁrst deﬁne sets of activities between which such relationships
will not exist:Echo
Echo HCU
Phys Test
Cons Card
Cons. Card.
Fig. 1. A trajectory (basic diagnosis pathway): ({Echo},{CC}, {EchoHCU,PhysTest},
{CC}).Deﬁnition 2. A set S = {s1, . . .,sm} of activities is called a parallel
activity set iff for all 1 6 i < j 6m, neither si  sj nor sj  si.
Notice that we use a rather loose concept of parallelism. It does
not enable to enforce that activities overlap in execution time, or
start/end simultaneously, as commonly encountered in formal
modeling languages for clinical guidelines [30].
When a patient actually receives care, precedence relationships
between the corresponding activities may exist, but not necessarily
so. The execution of some of the activities may overlap, or the reg-
istration may not be accurate enough (e.g. per day) to specify the
order. Consequently, the care received by a patient can be viewed
to exist of an ordered set of parallel activity sets:
Deﬁnition 3. A care set is the set of all parallel activities sets of
which the care received by a patient exists.
Trajectories model the real life situation where a prescribed or-
der exists between different parallel activity sets:
Deﬁnition 4. A trajectory T is a linearly ordered set (S1, . . .,Sm) of
parallel activity sets. (that is, for every Si, Sj, Sk 2 T, either Si  Sj or
Sj  Si, and Si  Sj and Sj  Sk together imply Si  Sk). For trajectory
T, the trajectory activity set A(T) is deﬁned as AðTÞ ¼ [mi¼1Si.
The interpretation of the precedence constraints in the deﬁni-
tion above is that if a precedence relation exists between two activ-
ity sets, i.e. S  S0, all activities in parallel activity set S must be
completed before any of the activities in parallel activity set S0
starts. An example trajectory is depicted in Fig. 1. In Fig. 1, the
precedence relationships between the parallel activity sets are
depicted using arrows, and hence the activities between which a
direct relationship is depicted by a line instead of an arrow are ele-
ments of a same parallel activity set.
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described as pathways. As will become clear below however, real
life clinical pathways refer to more complex process descriptions,
in which several different routings and sets of activities are feasi-
ble. Still, clinical pathways are prescriptions on the trajectories as
they may be executed in real life. We now constructively derive
a formal pathway deﬁnition from the deﬁnition of trajectories.
Pathways are deﬁned as the union of a set of mutually exclusive
trajectories and relations between these trajectories:
Deﬁnition 5. Let Tx and Ty be trajectories, let Sx 2 Tx be such that
Sa  Sx for all Sa 2 Tx, Sa– Sx, and let Sy 2 Ty be such that Sy  Sb for
all Sb 2 Ty, Sb– Sy. (In words, Sx is the last parallel activity set in Tx,
and Sy the ﬁrst activity set in Ty.) We say Tx precedes Ty, that is
Tx  Ty, iff Sx  Sy.Deﬁnition 6. A set K = {T1,T2, . . .,Tl} of trajectories is called unor-
dered if for each i, j,1 6 i, j 6 l,Ti  Tj nor Tj  Tl.Deﬁnition 7. A pathway P is a linearly ordered set {K1, . . .,Kz} such
that(a) each element is either a trajectory,
(b) an unordered set K = {k1, . . .,kl} of (one or more) pathways,
where a set of pathways is unordered iff any two trajecto-
ries, which are elements of two different pathways in K form
an unordered set of trajectories,
(c) A(S) \ A(T) = ;, for each two trajectories S and T which are
elements of (elements of) P.
The unordered sets in the pathway deﬁnition model exclusive
choice between alternative sub pathways of care. When providing
care, exactly one of the sub pathways must be selected:
Deﬁnition 8. A feasible realization R(P) of Pathway P is a pathway,
that is a linearly ordered set {r1, . . .,ry}, such that R(P) contains
exactly one element of each unordered set of P. For a given
pathway P, we deﬁne q(P) as the set of all feasible realizations of P.
Since a realization enforces a choice between the elements of an
unordered set, and trajectories are the linearly ordered elements of
the sub pathways at the bottom of the recursion of the pathway
deﬁnition, any feasible realization of a pathway forms a linearly or-
dered set of trajectories, and is therefore itself a trajectory.
Let us illustrate these principles using the example of Fig. 2. The
pathway depicted in Fig. 2 is an ordered set that consists of the
next three elements:
1. the trajectory {ECG, Cons Spec. Nurse, Lab tests, Echo, Check
diameter},
2. a set of two parallel pathways
a. a pathway consisting of the simple trajectory ; (the
empty set).
b. a pathway consisting of
i. Trajectory {CT Scan, TAAA},
ii. A set of two unordered pathways, each of which is a
trajectory:
1. {{Echo:HCU,Exercise},
2. {Echo(spec), {Exerc Test, LF: Antrup}}. Notice that
the second element of this trajectory forms a par-
allel activity set.3. the trajectory {Consult}.The interpretation of this diagnosis pathway is as follows. In
any feasible realization, the patient should ﬁrst receive the diag-
nostic steps {ECG, Cons Spec. Nurse, Lab tests, Echo, Check diameter}.
Then there is a choice between alternatives. If the diameter of theAorta does not exceed 5.5 cm, there is no further diagnosis. If it
does exceed this diameter, there is a choice between two further
diagnosis pathways, in the second of which there is no precedence
relation between the activities Exerc Test and LF: Antrup.. Each fea-
sible trajectory must be concluded by a Consult.
Using unordered sets of trajectories, the pathways deﬁned
above allowmodeling any variety of feasible realizations by explic-
itly specifying them (inefﬁciently) as elements of an unordered set.
On the other hand, when deﬁning a pathway that consists of a se-
quence of n unordered sets of 2 pathways each of which consists of
a single activity trajectory, one obtains a pathway that has 2n fea-
sible realizations. In general, the number of feasible realizations
can therefore be exponential in the input size. In all practical appli-
cations known to the authors however, the number of feasible real-
izations is bounded from above by a small constant.4. Methods: adherence modeling
Using the deﬁnitions above, we might speak of pathway adher-
ence if the trajectory that a patient follows is a feasible realization
of the pathway, or equivalently if the care a patient has received is
exactly according to one of the allowable prescriptions. For all
practical purposes however, this strict binary model – as often
encountered in the literature – is an oversimpliﬁcation of reality.
Deviations for good reasons are common in practice, and do not
necessarily incur a quality or efﬁciency loss. For instance, if an echo
or CT scan has been made recently, perhaps in another referring
hospital, its outcome might sufﬁce for the diagnosis, and hence
the corresponding activity can be skipped. This would mean an
efﬁciency gain, rather than an omission. In addition, if a certain de-
vice is out of order or has a long waiting list, ﬁnding a substitute for
an activity might be preferable over waiting. Moreover, the diagno-
sis trajectories of in-patients often interfere with other activities as
they are taking place by other medical disciplines in parallel. New
insights obtained during the diagnosis may lead to changing the
planned trajectory. Patients themselves might interrupt their pro-
cess for medical reasons, et cetera.
We conclude that (parts of) the potentially long trajectories that
patients undergo over a period can deviate from the clinical path-
ways, where some of the deviations are more signiﬁcant than oth-
ers. We now introduce a model, which is based on input of medical
experts, in which deviations of trajectories from clinical pathways
are measured on a numerical scale, allowing for a richer and more
meaningful discussion on the observed deviations.
The resulting measurement of deviations of trajectories repre-
senting the actual care received by patients is a non-trivial task be-
cause of the potentially complicated structure of clinical pathways
themselves. We continue our formal modeling approach to enable
measuring deviations. In the remainder, T refers to the trajectory
deﬁning the care a patient has actually received, whereas trajec-
tory R models a feasible realization of a clinical pathway P.
Deﬁnition 9. Let T and R be trajectories. A match M is a pair of
mappings MT:A(T)? {A(R) [ {-}} and MR: A(R)? {A(T) [ {-}} such
that:
(a) For each t 2 A(T),r 2 A(R),MT(t) = r,MR(r) = t. That is, the
restriction of MT to R is an injection, as is the restriction of
MR to T. However, several t 2 A(T), (r 2 A(R)) may have
MT(t) = (MR(r) = ).
(b) For t, t0 2 A(T), t  t0, and r,r0 2 A(R), such that MT(t) = r (or
equivalently MR(r) = t) and MT(t0) = r0 (or equivalently
MR(r0) = t0) it must hold that r  r0.
Moreover, we deﬁne l(T,R) as the set of all possible matches
M(T,R).
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d(M(T,R)) or simply d(M), is deﬁned as the sum over all the
deviation costs of the mappings of the elements, which are
calculated using the following three types of deviation cost:
(a) For each t 2 A(T) there is a set It of substitutes, – RIt, and for
each substitute g 2 It, the non-negative substitution costs are
denoted by c(t,g), where c(t,t) = 0.
(b) For each element t 2 A(T), the deviation cost c(t,) = cT, that
is the cost of mapping to a void is not dependent on t.
(c) For each element r 2 A(R), the deviation cost c(,r) = c(r),
that is the cost of mapping depends on the clinical pathway
activity r that remains unmatched.
Notice that b and c are in fact symmetrical deviations, incurring
a cost for leaving an element unmatched. As is clear from the dis-
cussion above, assigning costs to substitution or not matching
(matching to a void) is not an exact science. Our practical experi-
ments lead us to the conclusion that medical professionals typi-
cally reach consensus on costs from the categories a and c. We
consider category b costs to be less relevant and analyze them
parametrically below. Let it be noted however, that the computa-
tional complexity of the algorithms introduced below is not af-
fected when the deviation costs c(t,) are not constant.
With this model at hand, we now proceed to deﬁne the problem
formally:
Deﬁnition 11. Given a pathway P and a trajectory T, the adherence
A(T,P) of trajectory T to pathway P is deﬁned as:
Min
R2qðPÞ
Min
M2lðT;RÞ
dðMðT;RÞÞ:
This deﬁnition consists of two parts. Let us ﬁrst examine the inner
part, which minimizes for a given R, the deviation costs over all fea-
sible matches. Now noting that R is a feasible realization of pathway
P, the adherence problem is to determine the realization R with
lowest possible deviation costs. As there may be multiple feasible
realizations of a pathway and the deviation costs of a match are
not easy to calculate, adherence measurement is a highly non-triv-
ial problem.
For an example, consider again the pathway depicted in Fig. 2.
The trajectory {ECG, Cons Spec. Nurse, Lab tests, Echo, Check diame-
ter, Consult} forms a feasible realization of the pathway, where
the empty set is chosen as the alternative for the second pathway.
The trajectory {ECG, Cons Spec. Nurse, Lab tests, Echo, Check diame-
ter, CT Scan, TAAA, Echo:HCU, Exercise, Consult} forms a feasible real-
ization when the other pathway alternative is selected. The
trajectory {ECG, Cons Spec. Nurse, Lab tests, Echo, Check diameter,
CT Scan, Echo:HCU, Exerc Test, Consult} is an infeasible realization
of the pathway. In comparison to the ﬁrst pathway, it has redun-
dant activities {CT Scan, Echo:HCU, Exerc Test}. In comparison to
the second alternative, activity TAAA is missing. Moreover, the
activity ECHO:HCU should be followed by activity Exercise, or activ-
ity Exerc Test, should be preceded by Echo(spec) and preceded or
succeeded by LF: Antrup}}. Thus depending on the chosen realiza-
tion, the deviation is differently deﬁned, and so are the deviation
cost. The adherence measurement problem is to ﬁnd the realiza-
tion that minimizes the deviation cost. In fact, the deviation mea-
surement is already non-trivial when there are no unordered sub
pathways, which is the case considered in the algorithms below.
5. Methods: adherence measurement algorithms
We now proceed in steps to derive two algorithms to measure
the adherence of a trajectory T representing the care received by
a patient to a clinical pathway P. We restrict ourselves to the casewhere P is a trajectory, and therefore does not contain unordered
sets of sub pathways. This is an oversimpliﬁcation of reality as dis-
cussed in the case study. We have however not been able to pro-
vide an exact algorithm for the general case, and therefore
enumerate over all feasible choices of exclusive alternatives im-
plied by the unordered sets of sub pathways. The number of such
feasible choices never exceeds 10 in the case study at hand.
Thus we refrain ourselves to studying the problem of calculat-
ing the adherence of a trajectory to a trajectory. We start by con-
sidering the special case where all sets of parallel activities P and
T have cardinality one. In this special case, any realization R of P,
as well as T are linearly ordered sets of activities. This case corre-
sponds to the alignment problems discussed in relation to DNA se-
quences [33,36–38].
Let T = t1t2. . .tm and R = r1r2. . .rn be the two corresponding tra-
jectories (where the linear order increases with the indices). We in-
tend to ﬁnd a match M* such that
M ¼ arg min
M2lðT;RÞ
dðMÞ:
We deﬁne Ti = t1t2. . .ti and Rj = r1r2. . . rj, for i = 1. . .m,j = 1. . .n, and let
dði; jÞ ¼ min
M2lðTi ;RjÞ^MT ðtiÞ¼rj :
dðMÞ:
Deﬁning d(0,0) = 0, and taking the linear order into account, we
subsequently observe that
dðMÞ ¼ min
06i6;m;06j6n
dði; jÞ þ ðm iÞ  cT þ ðn jÞ  cR;:
We now establish a dynamic programming recursion for d(i,j).
Theorem 1. For i = 1. . .m, j = 1. . .n,dði; jÞ ¼ min
06I0<i;06j0<j
dði0; j0Þ þ ði i0Þ  cT þ ðj j0Þ  cR; þ cðti; rjÞ:Proof. Let Mij be a minimum deviation match of Ti and Rj, that is
Mij ¼ arg min
M2lðTi ;RÞÞ^MT ðtiÞ¼rj:
dðMÞ:
By deﬁnition MT(ti) = rj. Let i0, 1 6 i0 < i, be the maximum index for
which MTðti0 Þ– , and hence MTðti0 Þ ¼ rj0 , for some j0,1 6 j0 < j (we
let i0 = j0 = 0 if such i0 does not exist). By deﬁnition of i0 and because
of the linear order, all i00, i0 6 i00 < i, and all j00, j0 6 j00 < j, must have
MTðti00 Þ ¼ , resp.MRðrj00 Þ ¼ . Hence we conclude that d(Mij) = c(ti,r-
j) + (i  i0)  cT + (j  j0)  cR, + X, where X refers to the cost of the
restriction of the match M to Ti0 and Rj0 . Now, since d(Mij) is mini-
mum over all matches for Ti and Rj, we derive that X must be the
minimum cost of a match for Ti0 and Rj0 , such that MT(i0) = j0, mean-
ing that X = d(i0, j0), and indeed X = 0 = d(0,0) if i0 = j0 = 0. Now, by def-
inition of i0 and j0 we have that
dði0; j0Þ þ ði i0Þ  cT þ ðj j0Þ  cR; þ cðti; rjÞ
6 dði; jÞ þ ði iÞ  cT þ ðj jÞ  cR; þ cðti; rjÞ;
for all i,0 6 i < i, and all j,0 6 j < j, establishing the correctness
of the theorem. h
This result (re)establishes the correctness of the approach by
Needleman and Wunsch [36] for alignment of linear ordered sets.
The method proposed by Smith andWaterman [37] delivers, for gi-
ven T and R, two sub trajectories Ts ¼ ti0 ; . . . ; ti;1 6 i0 6 i 6 m and
Rs ¼ Ts ¼ rj0 ; . . . ; rj;1 6 i0 6 i 6 m such that d(M(Ts,Rs)) is minimum
over all possible choices of Ts and Rs. Improvements on the time
and space complexity of these and related algorithms are possible
[33,38].
In the medical context under consideration, the care set of a
patient, i.e. the set of all activities of which the care received by
866 J. van de Klundert et al. / Journal of Biomedical Informatics 43 (2010) 861–872the patient exists, often spans several departments and pathways.
Hence, in order to measure adherence for a speciﬁc clinical path-
way, one has to restrict the deviation to a subset of the trajectory
of a patient. This can be reasonably modeled by considering the fol-
lowing problem.
Deﬁnition 12. Given a pathway P and a trajectory T, the restricted
adherence RA(T,R) of trajectory T to pathway P is deﬁned as:
RAðT;RÞ ¼ Min
R2qðPÞ
Min
16i06i6m
Min
M2lðti0 ...ti ;RÞ
dðMÞ:
The special case of the restricted adherence problem where all
activity sets have cardinality one, can be solved by straightforward
extensions of the dynamic programming formulation of Theorem 1.
We now turn our attention to the more general case where R is
restricted to have parallel activity sets of cardinality one, but T is
not. In other words, the actual care received by a patient forms a
trajectory, which may contain activities whose execution has been
performed in parallel. This situation naturally arises when care is
registered per date, rather than in hours and minutes, or when
activities run in parallel indeed.
Let T = A1A2. . .Al and R = r1r2. . .rn be the two corresponding tra-
jectories, where the Ak, k = 1. . .l represent the parallel activity sets
of T, and in both trajectories the linear order increases with the
indices. We denote Ti = A1A2. . .Ai and Rj = r1r2. . .rj. As before, we in-
tend to ﬁnd a feasible match M* such that
M ¼ arg min
M2lðT;RÞ
dðMÞ:Deﬁnition 13. For 1 6 k 6 l,0 6 j0 < j 6 n, we deﬁne eðMðAk; rj0þ1
. . . rjÞÞ ¼ dðMðAk; rj0þ1 . . . rjÞÞ subject to MR(j) = t for some t 2 Ak.Lemma 1. For 1 6 k 6 l;0 6 j0 < j 6 n; eðMðAk; rj0þ1 . . . rjÞ can be cal-
culated in polynomial time.Proof. The value eðMðAk; rj0þ1 . . . rjÞÞ equals the minimum cost
induced by a match between the unordered elements of Ak and
the activities frj0þ1; . . . ; rjg, with the additional constraint that
MR(rj)– . Since there is no order on the elements of Ak, this min-
imum cost match is the solution to the minimum cost bipartite
maximum cardinality matching problem on the following bipartite
graph G(V1 \ V2,E). Vertex set V1 is the union of Ak and a set of j  j0
elements representing voids. Vertex set V2 is the union of
frj0þ1; . . . ; rjg and a set of jAkj elements representing voids. The
arc costs are deﬁned according to deﬁnition 10, and the arc costs
between two voids are zero. For the vertex rj in V2 only arcs con-
necting to elements of Ak exist which are in the substitute set Irj
(and no arcs connecting to voids). If jV2j > 1, vertices frj0þ1; . . . ;
rj  1g of V2 have arcs connecting to elements of Ak in their
respective substitute sets and to all voids in V1. Moreover each
vertex in V1 (representing an element of Ak) is connected to each
of the void vertices in V2. It is not hard to verify that the cost of a
minimum cost maximum cardinality matching in G equals
eðMðAk; rj0þ1 . . . rjÞÞ. This minimum cost maximum cardinality
matching can be found in polynomial time [34].
Enumeration over all k,j0,j,1 6 k 6 l,1 6 j0 < j 6 n, now allows
calculating all eðMðAk; rj0þ1 . . . rÞ in polynomial time. We now
present a polynomial time dynamic programming algorithm to
compute the minimum cost matching M*.
For 1 6 k 6 l,1 6 j 6 n, we deﬁne
eðk; jÞ ¼ min
ðM2lðTk ;RjÞ^ð9t2Ak such that MRðjÞ¼tÞ
dðMÞ;
and e(0,j) = 0 + j  cR,j = 0, . . .,n. hNow let us ﬁrst notice that dðMÞ ¼ min106k6l;06j6neðk; jÞ þ ðn jÞ
cR;þ
Pl
i¼kþ1 j Ai j
 
 cT . Hence the following recursion on e(k,j)
sufﬁces to ﬁnd d(M*):
Theorem 2. For k = 1. . .l,j = 1. . .n,
eðk; jÞ ¼ min
06k<k;06j<j
feðk; jÞ þ
Xk1
i¼kþ1
j Ai j
 !
 cT
þ eðMðAk; rjþ1 . . . rjÞÞg:Proof. Since eðk; jÞ ¼ min
ðM2lðTk ;RjÞ^ð9t2Ak0 ;k
06k such that MRðjÞ¼tÞÞ
dðMÞ and
the match implied by combining the match for Ak, to rjþ1 . . . rj
having value eðMðAk; rjþ1 . . . rjÞÞ and the match for Tk1 and Rj of
value min
06k<k;06j<j
eðk;jÞþ Pk1i¼kþ1 jAi j cT giving value eðk;jÞþPk1
i¼kþ1 jAi j
 
cT is a feasible solution for each choice of k,j,j*, we
have
eðk; jÞ 6 min
06k<k;06j<j
eðk; jÞ þ
Xk1
i¼kþ1
j Ai j
 !
 cT
( )
þ eðMðAk; rjþ1...rjÞÞ:
Let M^ be a minimum deviation match of Tk and Rj, where at least
one element of Ak is not matched to a blank. Thus d(M^) = (k,j).
Let j^ < j be the largest index such that for all
t 2 Ak;M^T ðtÞ 2 frj^þ1; . . . ; rjg [ fg, where j^ = 0 if MT(t) = r1 for
some t 2 Ak. Since M^RðjÞ ¼ t for some t 2 Ak, the precedence con-
straints imply that the elements of Ak+1,Ak+2, etc., cannot be mapped
to elements r1. . .rj in any feasible match. By deﬁnition of j^, the pre-
cedence constraints imply also that elements of t 2 Ak1,Ak2 etc.,
cannot be mapped to elements rj^+1. . .rn in any feasible match. Thus
only elements of Ak can be mapped to rj^+1. . .rj, and only elements of
Tk1 can be mapped to r1. . .rj^. Let j00 = arg max{06o6j^}MR(o)– ,
where j00 = 0 if such o does not exist. Let t^ be deﬁned as the match
of j00, i.e.MR(j00) = t^, and let k^ be the unique parallel activity set such
that t^ 2 Ak^. Then, we have
eðk; jÞ ¼ min
ðM2lðTk ;RjÞ^ð9t2Ak such that MRðjÞ¼tÞÞ
dðMÞ
¼ min
ðM^2lðTk^ ;Rj^ÞÞ
dðM^Þ þ
Xk1
i¼k^þ1
j Ai j
 !
 cT þ eðMðAk; rj^þ1 . . . rjÞÞ:
¼ eðk^; j^Þ þ
Xk1
i¼k^þ1
j Ai j
 !
 cT þ eðMðAk; rj^þ1 . . . rjÞÞ
P min
06k<k;06j6j
eðk; jÞ þ
Xk1
i¼kþ1
j Ai j
 !
 cT
( )
þ eðMðAk; rjþ1 . . . rjÞÞ: Corollary 1. Given a pathway P with parallel activity sets of cardinal-
ity one, and trajectory T, the (restricted) pathway adherence problem
can be solved in polynomial time.6. Case study results
The second and novel adherence measurement algorithm devel-
oped in the previous section enables to analyze data from the Car-
diovascular Center of MUMC. MUMC serves as an academic
hospital but also as the general hospital for the city of Maastricht
and vicinity. The academic function entails a considerable inﬂow
of non-standard patients for whose treatment strict adherence to
J. van de Klundert et al. / Journal of Biomedical Informatics 43 (2010) 861–872 867pathways is not considered to be of prime importance. On the
other hand, MUMC also has an inﬂow of patients for whom stan-
dardized pathways may provide optimal care. This situation has
the potential risk of providing non-standard care to patients for
whom standardized care is appropriate and vice versa. Hence,
the Cardiovascular Centre agreed on a procedure where standard-
ized diagnostic pathways are deﬁned for distinguishable patient
groups. In doing so, the complex patients are separated from stan-
dard cases, which are in turn classiﬁed in various groups. The ‘tri-
age’ process is the procedure by which patients are classiﬁed and
which determines which diagnostic pathway is appropriate, if
any. Early 2001, the Cardiovascular Centre established the set of
standardized diagnostic pathways whose structure is presented
in Fig. 3. The four pathways for which adherence is measured in
this research are visualized at the activity level in Fig. 4. The path-
way deﬁnitions have not changed over the years 2001–2005. As
medical insights regarding the four diagnosis processes may have
advanced over this time period, one must be careful when inter-St
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Fig. 3. Clinical pathways at cardpreting deviations from the pathways designed in 2001 measured
towards the end of the measurement period 2001–2005.
IT is often behind in pathway introductions [15], and so has it
been for MUMC’s cardiovascular centre. In particular, there is no
systematic electronic record keeping on the outcomes of the triage
processes.Wehaveuseddata fromtheﬁnancial information system,
which records all activities and the date at which they have taken
place. The data appears to be accurate and complete. As it is
irrelevant for ﬁnancial purposes, the exact start and end time of
the activities is not recorded. The patient trajectories therefore often
contain parallel activity sets. Since the outcomes of the triage
processes are not recorded, there is no information on which path-
way a patient is supposed to have followed. We have reconstructed
this triage outcome and pathway selection decision, by assigning
patients in retrospect to the pathways for which deviation is mini-
mum. Per pathway p per year y, n(p,y) is the estimate of medical ex-
perts of the number of patients (derived as a fraction of the total
patient population)which shouldhave followedpathwayp in year y.Exerc. thal.test
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J. van de Klundert et al. / Journal of Biomedical Informatics 43 (2010) 861–872 869Cardiac patients typically engage in a long term relationship
with the hospital, and many of them have co morbid conditions.
Hence patient data over a longer time interval, such as the ﬁve year
period 2001–2005 typically consists of hundreds of activities, by
various departments (not only the cardiovascular center), and are
stretched out over various years. Therefore they sharply contrast
the diagnosis pathways that typically consist of between 4 and
20 activities, which take place during a short period. Hence to
determine whether a diagnosis pathway has been followed by a
patient, we have chosen to match the diagnostic pathway to sub
patterns of trajectories [38] instead of matching them with com-
plete trajectories.
Ideally, a diagnostic pathway P matches perfectly to a sub pat-
tern of a trajectory T. In our experiments we give to this ideal
match a value of 0. For a given pathway P and trajectory T, let S*
be a sub pattern for which a match M* exists which minimizes
the value d(M*) over all possible matches M for sub patterns S of
T. Then S* and M* can be found using the algorithms presented in
the previous section, and the value d(M*) deviates from zero for a
combination of the following reasons (see also Deﬁnition 10):
(a) Activity a of P is mapped to a non-identical activity of S
yielding a deviation value from substitution between 0 and
10. These deviation values have been speciﬁed by medical
doctors of the cardiovascular center.Table 1
Computational results for cT = 0.
Pattern Years
2001
Aneurysm 1st decile 0.59
2nd decile 0.63
3d decile 0.65
4th decile 0.67
5th decile 0.67
6th decile 0.71
7th decile 0.72
8th decile 0.73
9th decile 0.75
10th decile 0.75
Stroke 1st decile 0.35
2nd decile 0.39
3d decile 0.44
4th decile 0.47
5th decile 0.48
6th decile 0.5
7th decile 0.53
8th decile 0.54
9th decile 0.56
10th decile 0.56
Heart failure 1st decile 0.63
2nd decile 0.74
3d decile
4th decile
5th decile
6th decile
7th decile
8th decile
9th decile
10th decile
Ischemic heart disease 1st decile 0.18
2nd decile 0.29
3d decile 0.36
4th decile 0.42
5th decile 0.45
6th decile 0.49
7th decile 0.53
8th decile 0.58
9th decile 0.64
10th decile 0.65(b) An activity of S is mapped to a blank ‘–’ and not to an activity
of P. For this case we report two scenarios, one in which the
deviation is valued 0, and one in which it is valued 1. For
various reasons, among which is co morbidity, unmapped
activities of S need not be undesirable deviations from P.
Hence a value of 0 might be appropriate. On the other hand,
if a diagnostic pathway is executed swiftly and according to
its deﬁnition, there is little room for unmapped activities.
This motivates the value of 1. Neither of these values is pref-
erable or perfect, and they do not form an exclusive optimal
set. We simply report computational results for both these
choices, and compare the outcomes.
(c) An activity of P is mapped to a blank ‘–’ and not to an activity
of S. In this case we assign the maximum deviation value of
10, unless a lower deviation value is suggested by a medical
expert of the cardiovascular center.
Using the thus deﬁned deviation values, we determine for each
P,S pair a maximum possible deviation Pmax, which results from
matching all activities of P and S to blanks. The computational re-
sults present normalized deviations d(M)/Pmax, 0 6 d(M)/Pmax 6 1,
for ease of interpretation. Obviously, smaller deviations represent
stricter adherence.
In our computational experiments we have cleaned up the data
set of originally 12,103 patients as follows. Firstly we have2002 2003 2004 2005
0.52 0.54 0.52 0.55
0.56 0.6 0.56 0.61
0.61 0.63 0.6 0.61
0.63 0.67 0.63 0.62
0.64 0.7 0.64 0.64
0.66 0.72 0.65 0.66
0.67 0.73 0.68 0.69
0.69 0.73 0.7 0.71
0.71 0.74 0.72 0.72
0.73 0.74 0.73 0.73
0.31 0.44 0.49 0.53
0.35 0.49 0.52 0.56
0.4 0.5 0.53 0.57
0.43 0.53 0.56 0.6
0.46 0.54 0.59 0.6
0.47 0.56 0.6 0.62
0.49 0.57 0.62 0.63
0.51 0.59 0.63 0.65
0.51 0.6 0.65 0.65
0.53 0.62 0.65 0.66
0.36 0.44 0.45 0.53
0.42 0.45 0.53 0.56
0.45 0.53 0.56 0.56
0.53 0.56 0.56 0.6
0.56 0.57 0.63 0.65
0.59 0.63 0.65 0.67
0.65 0.67 0.7 0.72
0.67 0.76 0.74 0.74
0.74 0.9 0.79 0.78
0.9 0.79
0.11 0.24 0.36 0.49
0.18 0.31 0.47 0.55
0.24 0.36 0.53 0.55
0.27 0.36 0.55 0.55
0.35 0.42 0.55 0.55
0.35 0.47 0.55 0.55
0.4 0.49 0.55 0.6
0.45 0.53 0.6 0.67
0.45 0.53 0.62 0.71
0.47 0.55 0.65 0.71
870 J. van de Klundert et al. / Journal of Biomedical Informatics 43 (2010) 861–872eliminated all patients who do not have both a ﬁrst consult (by
specialized nurse or medical doctor) and a ﬁnal consult (by medical
doctor). Second, we consider the data per year, allowing for a com-
parison over the years. Consequently, we assume that the diagnos-
tic pathways are not spread over multiple years. Thirdly, since the
chemical lab and blood tests consists of a set of activities, each
diagnostic pathway consists of around twenty activities. Since it
is supposed to be followed by a treatment, any patient who has
undergone a serious diagnosis process must have more than
twenty activities. On the other hand, we judge trajectories of more
than 500 activities, of which there is a limited number, as abnor-
mally long. Hence we have only considered trajectories of between
20 and 500 activities. As a result, we obtained 2471 patients for
2001, 6701 for 2002, 7542 for 2003, 7796 for 2004, and 5133 for
2005. (For the ﬁrst and last year our data covers only part of the
year). The sets of patients of different years overlap.
Table 1 presents the computational results for the base scenario
where the cost of leaving activities in the realized trajectory un-
matched is zero. There is a sub table for each pathway and each
sub tables has a column for each year. Per pathway p per year y,
the n(p,y) (or less) patients are sorted in increasing order of devia-
tion cost. For pathway p, column y, row i presents the deviation
cost of the patient at position bi  n(p,y)/10c in the sorted list, i.e.
the maximum deviation cost occurring in the ith decile of patients
selected to follow pathway p in year y.Table 2
Computational results for cT = 1.
Pattern Year
2001
Aneurysm 1st decile 0.66
2nd decile 0.71
3d decile 0.72
4th decile 0.72
5th decile 0.74
6th decile 0.76
7th decile 0.76
8th decile 0.76
9th decile 0.78
10th decile 0.8
Stroke 1st decile 0.37
2nd decile 0.44
3d decile 0.47
4th decile 0.5
5th decile 0.51
6th decile 0.51
7th decile 0.54
8th decile 0.56
9th decile 0.57
10th decile 0.59
Heart failure 1st decile 0.63
2nd decile 0.75
3d decile
4th decile
5th decile
6th decile
7th decile
8th decile
9th decile
10th decile
Ischemic heart disease 1st decile 0.33
2nd decile 0.39
3d decile 0.47
4th decile 0.49
5th decile 0.54
6th decile 0.58
7th decile 0.63
8th decile 0.65
9th decile 0.67
10th decile 0.72As 0 refers to perfect adherence, and 1 to complete lack of
adherence, all table entries are between 0 and 1. For ease of inter-
pretation we mention here that a normalized deviation of 0.5 cor-
responds to the case where the average deviation value of
elements of the pathway as obtained by mapping to substitutes
or blanks is 5 on the 10 point scale. Thus when the deviation cost
of received care is 0.5, it is as much like the prescribed pathway
as it is different from it.
In general the computational results reveal that in many cases,
the deviation is above 0.5. Ischemic heart disease appears to be the
exception, where especially in the early years 2001, 2002, low
deviation cost are observed. When considering how adherence
developed over time, one observes that for all pathways and for al-
most all deciles, the deviation cost went down from 2001 to 2002,
but increased since then, often resulting in largest deviations for
2005.
Table 2 provides the same results, but now for the scenario
where the deviation cost for unmatched activities from the realized
patient trajectories has value 1. For this case, the minimum devia-
tion penalty is still 0, but the maximum – non-normalized – abso-
lute deviation is higher, as the unmatched activities from the
realized patient trajectory each have deviation cost of 1 in addition
to the deviation cost of unmatched pathway activities. Neverthe-
less, we observe that the overall patterns of Table 1 reoccur in
Table 2, but that the normalized deviation cost have increased by2002 2003 2004 2005
0.62 0.67 0.64 0.61
0.67 0.72 0.66 0.65
0.7 0.74 0.71 0.7
0.72 0.75 0.73 0.72
0.72 0.76 0.74 0.73
0.74 0.77 0.76 0.74
0.75 0.78 0.76 0.75
0.76 0.79 0.76 0.76
0.77 0.82 0.77 0.78
0.78 0.82 0.79 0.78
0.37 0.53 0.56 0.57
0.43 0.56 0.57 0.6
0.44 0.59 0.6 0.65
0.47 0.6 0.62 0.65
0.51 0.63 0.63 0.66
0.51 0.63 0.65 0.66
0.51 0.63 0.66 0.66
0.53 0.64 0.66 0.66
0.54 0.65 0.67 0.68
0.56 0.66 0.68 0.69
0.46 0.55 0.56 0.56
0.53 0.56 0.56 0.56
0.56 0.59 0.56 0.56
0.59 0.62 0.63 0.64
0.59 0.64 0.66 0.68
0.64 0.66 0.68 0.72
0.66 0.68 0.71 0.76
0.68 0.72 0.75 0.79
0.72 0.79 0.79 0.79
0.79 0.8 0.79
0.23 0.39 0.49 0.56
0.32 0.44 0.54 0.56
0.37 0.49 0.56 0.56
0.39 0.51 0.56 0.56
0.44 0.54 0.56 0.56
0.47 0.54 0.61 0.61
0.47 0.56 0.63 0.67
0.51 0.6 0.67 0.72
0.53 0.61 0.68 0.72
0.54 0.61 0.72 0.72
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tories contain activities that do not belong to the clinical pathways.
7. Discussion
Despite scientiﬁc evidence that pathway implementations have
often failed to deliver efﬁciency and/or quality improvements,
large scale implementations of clinical pathways are worldwide
expected to bring improvements in the near future, as requested
by society. Scientiﬁc literature reveals that adopting clinical path-
ways in it self will not sufﬁce. Much attention must therefore be
paid to the design and improvement of the pathways as well as
to the actual, practical, execution of pathways after implementa-
tion. If not adhered to, pathway implementation likely fails to
bring improvement. We developed pathway adherence measure-
ment methods which cope with the dynamics and ﬂexibility of
pathways, and therefore with the deviations common to practice.
By developing an integral numerical adherence measure, as op-
posed to an activity based binary one, the models and methods rec-
ognize that deviation is not necessarily bad, yet allow scoring
deviations at various severity levels. Because of the potential im-
pact deviations from evidence based best practices may have on
the cost and quality of care on the one hand, and the importance
of customizing care to speciﬁc patients on the other hand, such a
balanced approach is needed and will hopefully contribute to path-
way acceptance as it has often obstructed implementation.
The models developed in this paper allow capturing the concept
of clinical pathways as practiced in MUMC as well as the patient
data. The patient data have been recorded for administrative pur-
poses and are therefore not complete regarding the exact order of
activities – they are exact with respect to the date – or reasons for
deviations from pathways. As we developed our model for these
data, it has limitations in its applicability for applications where
requirements and data capture more temporal detail. In particular,
the model does not capture concurrency (referring to the require-
ment where two or more activities must be performed simulta-
neously), or periodic activities. The inclusion of concurrency and/
or periodicity therefore forms a valuable extension. We refer again
to the literature on clinical guideline modeling languages [32] for
these and other model extensions, which apparently have not re-
ceivedmuch attention yet with respect to adherencemeasurement.
Thepresentmodel capturespartial orderings, and contains a con-
tinuous adherence measure that penalizes deviations in the form of
missing or substituted activities. Amodel variation that is worthy of
future research is the case where the ordering relationships are not
treated as hard constraints, but also addressed in the objective func-
tionbypenalizingdeviations fromthepartial order prescribed in the
pathway deﬁnition. Obviously, suchmodel modiﬁcations, as well as
the aforementionedmodiﬁcations relating to concurrency and peri-
odicity, affect the complexity of adherence measurement.
Although we have developed polynomial algorithms, time com-
plexity is certainly another area of improvement. Firstly, running
times on the practical instances which contain thousands of pa-
tients with long medical records are very long (in the order of
weeks). This is partly due to the absence of triage outcomes. On
the other hand, we have not been able to propose a polynomial
method for the case where the pathway and/or the actual patient
trajectory contain parallel activity sets of cardinality more than
one, requiring us to enumerate all feasible realizations. We conjec-
ture that this more general problem is NP-Complete, rendering a
polynomial method to be unlikely to exist. The complexity of this
problem and the variations suggested above are therefore an inter-
esting area of further research.
As is the case for several other adherence studies, the adherence
measured in the case study can be viewed to be quite low. Without
further analysis of the pathways and the medical cases at hand, weare unable to make a scientiﬁc normative statement about the ob-
served adherence. We urge however to conduct this analysis, as the
value of the methods and results is not in the adherence measure-
ment itself, but in the improvements in provided care that result
from it. In this respect, it is worth noticing that adherence im-
proved in the ﬁrst year, but diminished in subsequent years. A sim-
ilar phenomenon has been observed by Rood et al. [27].
Our methods rely on techniques from combinatorial optimiza-
tion problem and are akin to algorithms used for sequence align-
ment in genetic pathway analysis. The models and methods are
not limited to health care processes. Business process compliance
is an important issue in manufacturing and service industry. Hence
advances made in health care, may certainly also beneﬁt other ser-
vice industries.
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